S-E. Dahlén (Stockholm, Sweden), G. Brusselle (Ghent, Belgium)
Reproducible measurements of Th2-cytokines and RNA gene expression obtained in sputum from patients with allergic asthma following allergen challenge
M. Ruddy, C. Triboulay, R. Zuiker, N. Morelli, G. Tokiwa, R. Mogg, V. Rivas, K. Van Dyck, I. De Lepeleire, M. Tanen, A. Pica-Mendez, P. Hu, V. Malkov, Z. Diamant (Rahway, United States Of America; Brussels, Belgium; Leiden, Rotterdam, Netherlands)
|  |
Basement membrane, eosinophilic inflammation and urinary LTE4 in cough variant asthma and GER-induced chronic cough
C. Micheletto, S. Tognella, F. Trevisan, S. Bertacco, M. Visconti, R. Dal Negro (Bussolengo, Italy)
|  |
Predictive factors for asthma control according to ACQ5 in asthma patients treated with budesonide/formoterol maintenance and reliever therapy. Results from the EuroSMART study
M. Aubier, R. Buhl, J. Haughney, J. Ostinelli, T. Ekström, L. Jörgensen, O. C. P. van Schayck (Paris, Rueil-Malmaison, France; , Germany; Aberdeen, United Kingdom; Södertälje, Sweden; , Netherlands)
| |
Sodium cromoglycate inhibits release of mast cell mediators and bronchoconstriction following hyperpnea in athletes
J. Larsson, P. Kippelen, S. Anderson, J. Brannan, B. Dahlén, S. E. Dahlén (Stockholm, Sweden; West London, United Kingdom; Camperdown, Australia)
| |
Relationship between airway response to direct and indirect challenges and eosinophilic airways inflammation in elite athletes
N. Martin, M. Lindley, B. Hargadon, W. Monteiro, I. Pavord (Leicester, Loughborough, United Kingdom)
| |
Associations between clinical, laboratory and therapeutical parameters on admission and adverse outcomes in patients hospitalized for COPD exacerbations
A. Papaioannou, K. Bartziokas, M. Minas, A. Haniotou, K. Gourgoulianis, K. Kostikas (Larissa, Athens, Greece)
| |
Paradoxical trough effects of ‘triple therapy‘ on pulmonary function outcomes in COPD
P. A. Williamson, P. M. Short, K. L. Clearie, S. Vaidyanathan, T. C. Fardon, L. Howaniec, B. J. Lipworth (Dundee, United Kingdom)
| |
Proof of concept study to evaluate step down therapy with inhaled corticosteroid alone or additive therapy on surrogate inflammatory markers in asthma
L. McKinlay, P. A. Williamson, P. M. Short, B. J. Lipworth (Dundee, United Kingdom)
| |
The effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction
E. Daviskas, S. Anderson, S. Eberl, I. Young (Sydney, Australia)
| |
The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma
A. Lisitsa, I. Klimanov, S. Soodaeva (Moscow, Russian Federation)
| |
Lipopolysaccharide challenge in healthy smokers
R. Aul, J. Armstrong, R. Dockry, A. Woodcock, D. Singh (United Kingdom)
| |
Monitoring of monoclonal antibody therapy with a new recovery ELISA assay technique (R-ELISA®)
P. Strohner, A. Staatz, A. Schäfer, G. Becher, D. Sarrach, J. Reich, J. O. Steiss, T. Häupl (Berlin, Bernau, Germany)
| |
Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis
F. Kellett, R. Niven (Warrington, United Kingdom)
| |
Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis
H. Pyne, B. Kane, R. O‘Driscoll (United Kingdom)
| |
Difficulties of recurrent bronchoobstructive syndrome treatment in pediatric patients with remote sequelae of bronchopulmonary dysplasia
O. Matsyura, L. Besh (Ukraine)
| |
Key attributes of inhalers for patients versus physicians
N. Roche, M. Small, D. Price (Paris, France; Macclesfield, Aberdeen, United Kingdom)
| |
Patient-reported outcomes (PROs) and reliever use in Japanese and European patients with chronic obstructive pulmonary disease receiving formoterol 4.5 and 9μg twice daily: Results of the OCEAN phase III study
M. Ichinose, H. Aizawa, Y. Fukuchi, M. Mishima, M. Nishimura, M. Bogdan (Wakayama, , Tokyo, Sapporo, Japan; Bucharest, Romania)
| |
Airway resistance assessed by impulse oscillometry at varying respiratory rate and the effect of pretreatment with short-acting β2 agonist in COPD patients
H. Iwamoto, Y. Haruta, M. Nakagawa, S. Miyamoto, N. Hattori, N. Kohno (Japan)
| |
Roflumilast in coadministration with medications commonly prescribed for COPD: An overview of existing studies
G. Lahu, U. M. Goehring, A. Hünnemeyer, N. Nassr (Konstanz, Germany)
| |